Deciphering the Active Compounds and Mechanisms of HSBDF for Treating ALI via Integrating Chemical Bioinformatics Analysis

The Huashi Baidu Formula (HSBDF), a key Chinese medical drug, has a remarkable clinical efficacy in treating acute lung injury (ALI), and it has been officially approved by the National Medical Products Administration of China for drug clinical trials. Nevertheless, the regulated mechanisms of HSBDF...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanru, Jin, Xiaojie, Fan, Qin, Li, Chenghao, Zhang, Min, Wang, Yongfeng, Wu, Qingfeng, Li, Jiawei, Liu, Xiuzhu, Wang, Siyu, Wang, Yu, Li, Ling, Ling, Jia, Li, Chaoxin, Wang, Qianqian, Liu, Yongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201258/
https://www.ncbi.nlm.nih.gov/pubmed/35721141
http://dx.doi.org/10.3389/fphar.2022.879268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201258/
https://www.ncbi.nlm.nih.gov/pubmed/35721141
http://dx.doi.org/10.3389/fphar.2022.879268

Ejemplares similares